NOACs for Stroke Prevention in Patients With Atrial Fibrillation and Previous ICH "NASPAF-ICH"


Phase 2 Results N/A

Summary of Purpose

To determine the feasibility of a controlled trial examining the efficacy and safety of non-vitamin K antagonist oral anticoagulants (NOACs) compared with ASA for stroke prevention in patients with a high-risk of atrial fibrillation and previous intracerebral hemorrhage.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 December 2017.

26 Apr 2017 25 Nov 2016 1 Oct 2019 1 Jan 2020 1 Dec 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available